What Happened?
, -based Haemonetics Appointed James D\'Arecca as Chief Financial Officer
About the Company
We believe that through proper blood management, our products and services can help our commercial plasma and blood center customers optimize their collection processes. We seek to help ensure a continual supply of high-quality plasma for biopharmaceuticals and blood components for therapeutic use at optimal costs, along with better blood management processes. Working with our hospital customers, we seek to prevent a blood transfusion to the patient who doesn’t need one, or, if a transfusion is necessary, to ensure the transfusion of the right blood product, at the right time, in the right dose to the patient who does.
About the Person
James D'Arecca is Chief Financial Officer at Haemonetics. Previously, James held various senior HR leadership roles in the industry.
Info Source
News
Short Profile